- Egypt rights center raided, 2 Mubaraks acquitted
- New Mexico Supreme Court rules same-sex marriage constitutional
- Blame Bush: 5 years later, that’s still the mantra, pollsters find
- Dutch prostitutes demand same retirement benefits as soccer stars
- John McCain to Harry Reid: I’ll ‘kick the crap’ out of you
- Dogs that talk: Researchers seek $10K for ‘No More Woof’ technology
- 1,000 firefighters called to battle stubborn Big Sur wildfire
- Black Friday brouhaha: Millions of Target shoppers hit by credit card theft
- Britain orders airplane to rescue citizens from violent South Sudan
- Mega Millions winner emerges as Georgia mom, in ‘disbelief’
FDA panel wants more restrictions on painkillers
Question of the Day
WASHINGTON (AP) - Federal health advisers said Friday a government proposal to curb misuse of powerful painkillers does not go far enough to fix a problem linked to hundreds of fatal overdoses annually.
The Food and Drug Administration summoned a panel of 35 outside experts to review its plan to reduce the misuse and abuse of long-acting pain relievers. The agency’s plan consists mainly of educating doctors and patients about appropriate use of the drugs.
But the FDA panel voted 25-10 to reject the agency’s proposal, saying more requirements and training are needed for health professionals who prescribe the drugs.
The government’s proposal would apply to extended release versions of opioid narcotics like morphine, oxycodone and methadone.
In one key disagreement with the FDA, panelists said doctors who prescribe opioids should be required to undergo training. The FDA suggested in its briefing that making such training mandatory could be overly burdensome, since the drugs are prescribed by thousands of physicians across the U.S.
Panelists also questioned whether the FDA’s so-called “risk evaluation and mitigation strategy,” or REMS, would have any significant impact on the epidemic of opioid abuse, which is responsible for more fatal overdoses each year than heroin and cocaine combined.
“We freely acknowledged that the REMS cannot address the entire scope of the problems for society on prescription drug misuse and abuse,” Jenkins told reporters in a post-meeting news conference.
The government’s risk management plan is specific to extended release versions of opioid drugs, which come in both pill and patch forms and are designed to give long-lasting effects. That potency carries serious risks when patients abuse them as stimulants.
Some panelists suggested FDA restrictions should also expand to more conventional, immediate-release painkillers.
The FDA has issued a number of warnings on prescription pain relievers in recent years but with little success. A federal survey conducted in 2007 found 5.2 million people in the U.S. reported using prescription pain drugs inappropriately.
The companies most likely to be impacted by new regulations include Purdue Pharmaceuticals, maker of the blockbuster pill OxyContin, and King Pharmaceuticals, which markets Embeda morphine capsules.
By Michael P. Orsi
Edward Snowden should declare his patriotism in court
- Citing 'unfair system,' Obama commutes sentences for 8 crack offenders
- Homeland Security helps smuggle illegal immigrant children into the U.S.
- Gov't wasted $30 billion on 'pillownauts,' crystal goblets -- buying human urine!
- Bill Gates: The Secret Santa disguised as a 'friendly fellow' on Reddit
- KELLNER: It's not a Merry Christmas for the persecuted church
- PRUDEN: 'Tis the season for apologies
- Special ops vets slam military benefit cuts
- ORSI: No greater act of loyalty to the Constitution
- TRIPLETT: Shale revolution reality checks
- Obama sends 45 service members to South Sudan
Independent voices from the The Washington Times Communities
Southern Fried Politics from the Lens of a Persian-American Millennial
All of the world’s problems, solved on your back porch
Paul Rondeau exposes the propaganda, media tricks, and government policies that undermine our families, faith, freedom…and even life itself
Implement these actionable tips, how-to’s and best practices in 10 minutes or less to leverage online communications and technology for brand, business and career development.
Top 10 handguns in the U.S.
Extraordinary day at Redskins Park
White House pets gone wild!
Let it snow